Evaluate the Survival Benefits of Zemplar Versus Calcijex in Subjects w/ Stage V Chronic Kidney Disease on Hemodialysis

Clinical trial NCT00062699 · TERMINATED

Trial details

NCT number: NCT00062699
Sponsor: Abbott
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

End-Stage Kidney Disease

Start date: 2003-04-01
Enrollment: 2200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.